Platinum Equity’s Post

Big news in the health sector! Johnson & Johnson just revealed a stellar performance this quarter, with medical device sales taking center stage. Their adjusted earnings blew past expectations, with a notable upturn in medtech, fuelled by a post-pandemic rush for surgeries. However, it's not all about the numbers. J&J demonstrates remarkable resilience and innovation with strategic acquisitions shaping a bright future in cardiovascular tech. And for those invested, marks your calendars - they've just upped their dividend in a decades-long streak of increases. Keeping health at the forefront and financials in check, J&J sets a robust example of growth and governance. What's your take on this healthcare heavyweight's latest moves? #JohnsonAndJohnson #HealthcareInnovation #FinancialResults

this is huge, but to emphasize the "huge-ness" of this (beyond the $B word dollars floating around), it helps to use the wide field lense additional perspective here matters. Owen's & Minor picked up (finalized) Apria in March 2022 for 1.6 billion dollars... Now granted , Rotech is more than respiratory (and O&M's Byram Healthcare is more than #respiratory) , but the respiratory market footprint Rotech occupies is substantial , now combine it w/ Apria , and the scaling here is- to put it lightly , substantial. This creates quite the HME DME entity above and beyond where they already were. #Homecare #homehealth #hme #dme #respiratorycare #mechanicalventilation

Big news in the health sector! Johnson & Johnson just revealed a stellar performance this quarter, with medical device sales taking center stage. Their adjusted earnings blew past expectations, with a notable upturn in medtech, fuelled by a post-pandemic rush for surgeries. However, it's not all about the numbers. J&J demonstrates remarkable resilience and innovation with strategic acquisitions shaping a bright future in cardiovascular tech. And for those invested, marks your calendars - they've just upped their dividend in a decades-long streak of increases. Keeping health at the forefront and financials in check, J&J sets a robust example of growth and governance. What's your take on this healthcare heavyweight's latest moves? #JohnsonAndJohnson #HealthcareInnovation #FinancialResults

WELL is pleased to announce several important updates to its Canadian clinic business, reflecting strong growth momentum and return on invested capital (ROIC) performance. Some key highlights include: 🚀 In the last 10 days, WELL has closed the acquisition of 3 primary care clinics in BC and executed definitive agreements to acquire 4 diagnostic imaging clinics in Alberta with combined revenues of $17M at 7% operating margins, not including post transaction synergies. 🚀 WELL acquired or absorbed 21 clinics in Q4 2023 inclusive of legacy MCI OneHealth and MB Clinic networks and 10 clinics from Shoppers Drug Mart in June 2024 which are now all operating profitably on an Adjusted EBITDA basis. 🚀 WELL’s acquisition and absorption pipeline has grown to 5 signed LOIs representing $11.8M in revenues at 5% operating margins and more than 50 clinics in pre-LOI review. 🚀 WELL’s Canadian Clinics Business operates at a pre-tax unlevered Return on Invested Capital (ROIC) of approximately 14%. Within this, the ROIC for Primary Care is around 25%, while WELL Health Diagnostic Centres achieves approximately 11%. Hamed Shahbazi, Founder and CEO of WELL, commented, “Our primary care network has achieved figures of approximately 25%, demonstrating our ability to consistently create value." Read WELL's latest press release for further details. https://ow.ly/I6NT50Tk45z

PatientFi, a company offering medical practices a comprehensive technology suite of payment and subscription solutions to help patients pay for elective procedures, today announces the closing of a significant growth equity financing led by new investor Questa Capital, a venture growth equity firm focused on expansion-stage healthcare companies, with participation from the company’s existing investors. PatientFi intends to use the proceeds to cement its position as a market leader in its core specialties for elective healthcare practices and their patients. The growth capital will be used primarily for accelerating sales and marketing, developing new commercial partnerships, and launching new product initiatives. Read more: https://lnkd.in/dqpAdqpA Todd Watts #fundraising #funding #fintech #finance #FinancialIT

✅ Key takeaways: 🟣 BD today announced it signed a definitive agreement to acquire Edwards Lifesciences‘ (NYSE: EW) + Critical Care business. 🔵 The Franklin Lakes, N.J.-based company will pay $4.2 billion in cash for the patient monitoring business segment. Critical Care will operate in Irvine, California as a separate business unit within the BD Medical segment, and will be led by Katie Szyman, corporate VP of Critical Care at Edwards. 🟡 BD plans to fund the all-cash transaction with approximately $1 billion of cash and $3.2 billion of new debt. Subject to customary regulatory reviews and closing conditions, the transaction is expected to close before the end of the calendar year. 🔴 Company executives expect the transaction to be immediately accretive to all financial measures and to yield strong returns. Critical Care generated over $900 million in revenue in 2023 and has approximately 4,500 employees.

Northern Ireland family healthcare business drives European expansion with acquisition of Belgium firms

And so to our next chapter….. Exciting times ahead, more collaborations, more options and solutions to offer all of our #orthopaedic #surgeons and #patients looking forward to rising to the new challenges! 🦾 #customerfocussed #puttingpatientsfirst #strongertogether #creatingbettertogether

Explore why Ortho Carolina enthusiastically endorses Montecito Medical to fellow physicians and groups. Initially contemplating refinancing, concerns about partnership issues prompted them to seek alternatives. Montecito's unique approach, acquiring properties while allowing partners to retain equity (up to 15%), proved to be the ideal solution. Two years later, participating in the resale allowed them to maintain their equity position with added tax advantages. Watch the video to learn more 📺 👀 https://bit.ly/3SnpcSy #OrthoCarolina #MontecitoMedical #RealEstateSolution #PhysicianPartnershipSuccess #RealEstateInvesting #HealthcareRealEstate #MedicalProperties #PropertyInvestment #CommercialRealEstate #InvestInHealth #RealEstateSuccess #PhysicianOwnership #HealthcareInvestments #PropertySolutions #MedicalOfficeSpaces #InvestmentOpportunity #EquityRetention #RealEstatePartnership

Another big-ticket deal in #healthcare is in the offing Apax to put Healthium Medtech Limited on the block. The Economic Times exclusive #mergersandacquisitions #privateequity #deals #investmentbanking #sutures #medicaldevices #hospitals #surgicalinstruments #indianeconomy #ethicon